Correction to: Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors (Cancer Immunology, Immunotherapy, (2022), 10.1007/s00262-022-03151-2)

Mitchell S. von Itzstein, Amrit S. Gonugunta, Yiqing Wang, Thomas Sheffield, Rong Lu, Sadia Ali, Farjana J. Fattah, Donglu Xie, Jennifer Cai, Yang Xie, David E. Gerber

Research output: Contribution to journalComment/debatepeer-review

Abstract

The article Divergent prognostic effects of pre‑existing and treatment‑emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors, written by Mitchell S. von Itzstein, Amrit S. Gonugunta, Yiqing Wang, Thomas Sheffield, Rong Lu, Sadia Ali, Farjana J. Fattah, Donglu Xie, Jennifer Cai, Yang Xie and David E. Gerber, was originally published electronically on the publisher’s internet portal on 24 January 2022 without open access.

Original languageEnglish (US)
JournalCancer Immunology, Immunotherapy
DOIs
StateAccepted/In press - 2022

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Correction to: Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors (Cancer Immunology, Immunotherapy, (2022), 10.1007/s00262-022-03151-2)'. Together they form a unique fingerprint.

Cite this